BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38415361)

  • 1. GDF11 level and its effect on prognosis in patients with acute myeloid leukemia.
    Aslan NA; Avcı E; Şenol H; Güler N
    J Investig Med; 2024 Apr; 72(4):341-348. PubMed ID: 38415361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GDF11 promotes osteogenesis as opposed to MSTN, and follistatin, a MSTN/GDF11 inhibitor, increases muscle mass but weakens bone.
    Suh J; Kim NK; Lee SH; Eom JH; Lee Y; Park JC; Woo KM; Baek JH; Kim JE; Ryoo HM; Lee SJ; Lee YS
    Proc Natl Acad Sci U S A; 2020 Mar; 117(9):4910-4920. PubMed ID: 32071240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of the WFIKKN2 follistatin domain reveals insight into how it inhibits growth differentiation factor 8 (GDF8) and GDF11.
    McCoy JC; Walker RG; Murray NH; Thompson TB
    J Biol Chem; 2019 Apr; 294(16):6333-6343. PubMed ID: 30814254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follistatin dysregulation impaired trophoblast biological functions by GDF11-Smad2/3 axis in preeclampsia placentas.
    Li H; Zhou L; Zhang C; Xi Q; Lv J; Huo W; Zhu L; Zhu R; Zhang Y
    Placenta; 2022 Apr; 121():145-154. PubMed ID: 35339026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential antagonism of activin, myostatin and growth and differentiation factor 11 by wild-type and mutant follistatin.
    Schneyer AL; Sidis Y; Gulati A; Sun JL; Keutmann H; Krasney PA
    Endocrinology; 2008 Sep; 149(9):4589-95. PubMed ID: 18535106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of Circulating Growth and Differentiation Factors 8 and 11 and Their Antagonists as Measured Using Liquid Chromatography-Tandem Mass Spectrometry With Age and Skeletal Muscle Strength in Healthy Adults.
    Semba RD; Zhang P; Zhu M; Fabbri E; Gonzalez-Freire M; Carlson OD; Moaddel R; Tanaka T; Egan JM; Ferrucci L
    J Gerontol A Biol Sci Med Sci; 2019 Jan; 74(1):129-136. PubMed ID: 30380014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between transforming growth factor β superfamily members (GDF11 and BMP4) and lumbar spine bone mineral density in postmenopausal Chinese women.
    Han W; Bai XJ; Han LL; Chen XM; Sun XF
    Arch Gynecol Obstet; 2022 Mar; 305(3):737-747. PubMed ID: 34417839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in GDF11 and the extracellular antagonist, Follistatin, as a likely cause of Mendelian forms of orofacial clefting in humans.
    Cox TC; Lidral AC; McCoy JC; Liu H; Cox LL; Zhu Y; Anderson RD; Moreno Uribe LM; Anand D; Deng M; Richter CT; Nidey NL; Standley JM; Blue EE; Chong JX; Smith JD; Kirk EP; Venselaar H; Krahn KN; van Bokhoven H; Zhou H; Cornell RA; Glass IA; Bamshad MJ; Nickerson DA; Murray JC; Lachke SA; Thompson TB; Buckley MF; Roscioli T
    Hum Mutat; 2019 Oct; 40(10):1813-1825. PubMed ID: 31215115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TERT assists GDF11 to rejuvenate senescent VEGFR2
    Zhao L; Zhang S; Cui J; Huang W; Wang J; Su F; Chen N; Gong Q
    Lab Invest; 2019 Nov; 99(11):1661-1688. PubMed ID: 31292540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth differentiation factor 11: A proangiogenic drug as a potential antiaging regulating molecule.
    Rochette L; Dogon G; Rigal E; Zeller M; Cottin Y; Vergely C
    Arch Cardiovasc Dis; 2023 Jan; 116(1):41-46. PubMed ID: 36572608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of GDF11 during inflammation - An overview.
    Machelak W; Szczepaniak A; Jacenik D; Zielińska M
    Life Sci; 2023 Jun; 322():121650. PubMed ID: 37011872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of concurrent training order on body composition and serum concentrations of follistatin, myostatin and GDF11 in sarcopenic elderly men.
    Bagheri R; Moghadam BH; Church DD; Tinsley GM; Eskandari M; Moghadam BH; Motevalli MS; Baker JS; Robergs RA; Wong A
    Exp Gerontol; 2020 May; 133():110869. PubMed ID: 32035222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and Clinical Significance of N-cadherin in Bone Marrow Leukemic Cells Derived from Patients with Acute Leukemia].
    Ma J; Liu YJ; Zhang QT; Yu QF; Zhang ZF; Zhang MY; Wang C; Gan SL; Chen SM; Cao WJ; Xie XS; Yan-Fang L; Liu LX; Wan DM; Wang F; Sun L; Sun H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1312-1318. PubMed ID: 27784348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [GDF11 level in patients with myelodysplastic syndrome and its clinical significance].
    Han Y; Wang H; Fu R; Qu W; Ruan E; Wang X; Wang G; Wu Y; Liu H; Song J; Guan J; Xing L; Li L; Jiang H; Liu H; Wang Y; Liu C; Zhang W; Shao Z
    Zhonghua Yi Xue Za Zhi; 2016 Mar; 96(8):620-4. PubMed ID: 26932855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating GDF11 levels are decreased with age but are unchanged with obesity and type 2 diabetes.
    Añón-Hidalgo J; Catalán V; Rodríguez A; Ramírez B; Silva C; Galofré JC; Salvador J; Frühbeck G; Gómez-Ambrosi J
    Aging (Albany NY); 2019 Mar; 11(6):1733-1744. PubMed ID: 30897065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships of GDF8 and 11 and Their Antagonists With Decline of Grip Strength Among Older Adults in the Baltimore Longitudinal Study of Aging.
    Yamaguchi Y; Zhu M; Moaddel R; Palchamy E; Ferrucci L; Semba RD
    J Gerontol A Biol Sci Med Sci; 2023 Oct; 78(10):1793-1798. PubMed ID: 37235639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candidate rejuvenating factor GDF11 and tissue fibrosis: friend or foe?
    Frohlich J; Vinciguerra M
    Geroscience; 2020 Dec; 42(6):1475-1498. PubMed ID: 33025411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activin and GDF11 collaborate in feedback control of neuroepithelial stem cell proliferation and fate.
    Gokoffski KK; Wu HH; Beites CL; Kim J; Kim EJ; Matzuk MM; Johnson JE; Lander AD; Calof AL
    Development; 2011 Oct; 138(19):4131-42. PubMed ID: 21852401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GDF11 Inhibits Bone Formation by Activating Smad2/3 in Bone Marrow Mesenchymal Stem Cells.
    Lu Q; Tu ML; Li CJ; Zhang L; Jiang TJ; Liu T; Luo XH
    Calcif Tissue Int; 2016 Nov; 99(5):500-509. PubMed ID: 27395058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exogenous GDF11 attenuates non-canonical TGF-β signaling to protect the heart from acute myocardial ischemia-reperfusion injury.
    Su HH; Liao JM; Wang YH; Chen KM; Lin CW; Lee IH; Li YJ; Huang JY; Tsai SK; Yen JC; Huang SS
    Basic Res Cardiol; 2019 Mar; 114(3):20. PubMed ID: 30900023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.